2024 ICD-10-CM Diagnosis Code C53.9

by

Malignant neoplasm of cervix uteri, unspecified

  • C53.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C53.9 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C53.9 – other international versions of ICD-10 C53.9 may differ.

ICD-10-CM Coding Rules

  • C53.9 is applicable to female patients.

The following code(s) above C53.9 contain annotation back-references

 that may be applicable to C53.9:

  • C00-D49  Neoplasms
  • C51-C58  Malignant neoplasms of female genital organs
  • C53  Malignant neoplasm of cervix uteri

Approximate Synonyms

  • Adenocarcinoma of cervix
  • Cancer of the uterine cervix
  • Cancer of the uterine cervix, adenocarcinoma
  • Cancer of the uterine cervix, invasive
  • Cancer of the uterine cervix, squamous cell
  • Carcinoma of uterine cervix, invasive
  • Malignant tumor of cervix
  • Primary adenocarcinoma of uterine cervix
  • Primary malignant neoplasm of uterine cervix
  • Squamous cell carcinoma of cervix

Clinical Information

  • Primary or metastatic malignant neoplasm involving the cervix.
  • The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cervical cancer is caused by a virus called hpv. The virus spreads through sexual contact. Most women’s bodies are able to fight hpv infection. But sometimes the virus leads to cancer. You’re at higher risk if you smoke, have many children, use birth control pills for a long time, or have hiv infection. Cervical cancer may not cause any symptoms at first. Later, you may have pelvic pain or bleeding from the vagina. It usually takes several years for normal cells in the cervix to turn into cancer cells. Your health care provider can find abnormal cells by doing a pap test – examining cells from the cervix under a microscope. If there are abnormal cells, you will need a biopsy. By getting regular pap tests and pelvic exams you can find and treat any problems before they turn into cancer.treatment may include surgery, radiation therapy, chemotherapy, or a combination. The choice of treatment depends on the size of the tumor, whether the cancer has spread and whether you would like to become pregnant someday.vaccines can protect against several types of hpv, including some that can cause cancer. nih: national cancer institute

ICD-10-CM C53.9 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
  • 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
  • 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
  • 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
  • 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
  • 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
  • 754 Malignancy, female reproductive system with mcc
  • 755 Malignancy, female reproductive system with cc
  • 756 Malignancy, female reproductive system without cc/mcc

Convert C53.9 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to C53.9: